Vanguard Group’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNPX
TRCT
CVM
MWA
SS
HWM
Vanguard Group's GNPX Position: Q4 2025 in Review
Vanguard Group sold out of Genprex (GNPX) in Q4 2025, closing a stake of 394 shares — an estimated $73.2K sold.
Vanguard Group first reported a position in GNPX in Q3 2019 and held it in 24 quarters. The position peaked at $8.03M in Q1 2021. 9 funds tracked by Wall St. Rank hold GNPX as of Q4 2025.
- Vanguard Group reported no remaining Genprex position as of Q4 2025 after selling out during the quarter.
- Vanguard Group sold 394 Genprex shares in Q4 2025, an estimated $73.2K.
- Vanguard Group first reported a position in Genprex in Q3 2019 and held it in 24 quarters.
- Vanguard Group's Genprex position peaked at $8.03M in Q1 2021.
- 9 funds tracked by Wall St. Rank held Genprex as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.